GL Pharm Tech Corp. (KOSDAQ:204840)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,224.00
-7.00 (-0.57%)
At close: Dec 5, 2025
13.54%
Market Cap 94.92B
Revenue (ttm) 34.30B
Net Income (ttm) 307.33M
Shares Out 77.55M
EPS (ttm) 4.24
PE Ratio 288.73
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 166,245
Average Volume 226,550
Open 1,231.00
Previous Close 1,231.00
Day's Range 1,198.00 - 1,231.00
52-Week Range 900.00 - 1,844.00
Beta 0.95
RSI 52.60
Earnings Date Mar 18, 2026

About GL Pharm Tech

GL Pharm Tech Corp. provides generic drugs and incrementally modified drug (IMD) formulation technology to pharmaceutical companies in South Korea. The company offers IMD for gastritis, antidepressant, anorectic, and antibiotic indications. It also provides generic drugs for cardiovascular, urology, pain, anti-infection, gastric disease, diabetes, central nervous system disease, respiratory disease, transplantation, and other areas. In addition, the company engages in developing new molecule entity pipeline products for dry eye disease. Further... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 33
Stock Exchange KOSDAQ
Ticker Symbol 204840
Full Company Profile

Financial Performance

In 2024, GL Pharm Tech's revenue was 26.05 billion, an increase of 0.06% compared to the previous year's 26.03 billion. Losses were -2.34 billion, -37.64% less than in 2023.

Financial Statements

News

There is no news available yet.